| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.31e-07 | 303 | 55 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.08e-05 | 562 | 55 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA6 KMT2D RBM33 RPTOR BRD4 MED12L RERE ZMIZ1 BCL9 PRDM16 | 2.73e-04 | 1160 | 55 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIVEP3 HNF1A KMT2D BCL11B AEBP1 ZNF652 BARHL2 YLPM1 ZBTB22 ETV5 PRDM16 CASZ1 | 3.79e-04 | 1412 | 55 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 8.31e-04 | 560 | 55 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 8.84e-04 | 566 | 55 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA6 KMT2D RBM33 RPTOR BRD4 MED12L RERE ZMIZ1 BCL9 PRDM16 | 1.02e-03 | 1356 | 55 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | SMAD binding | 1.72e-03 | 86 | 55 | 3 | GO:0046332 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L NCOA6 HNF1A KMT2D BCL11B BRD4 BARHL2 MED12L CHCHD2 ETV5 SSBP2 ZMIZ1 BCL9 PRDM16 PHIP CASZ1 | 5.26e-07 | 1390 | 56 | 16 | GO:0045944 |
| HumanPheno | Diagnostic behavioral phenotype | KMT2D BCL11B RBM12 BRD4 SBF2 PCDH15 MED12L RERE ZMIZ1 USH2A PRDM16 CASZ1 MFF PHF21A | 5.90e-06 | 747 | 27 | 14 | HP:0025783 |
| HumanPheno | Polyphagia | 4.59e-05 | 78 | 27 | 5 | HP:0002591 | |
| HumanPheno | Bifid ribs | 8.60e-05 | 17 | 27 | 3 | HP:0000892 | |
| HumanPheno | Rib fusion | 1.04e-04 | 48 | 27 | 4 | HP:0000902 | |
| Domain | BCL9_beta-catenin-bd_dom | 9.48e-06 | 2 | 58 | 2 | IPR024670 | |
| Domain | BCL9 | 9.48e-06 | 2 | 58 | 2 | PF11502 | |
| Domain | Bcl-9 | 9.48e-06 | 2 | 58 | 2 | IPR015668 | |
| Domain | BROMODOMAIN_1 | 2.05e-04 | 37 | 58 | 3 | PS00633 | |
| Domain | Bromodomain | 2.22e-04 | 38 | 58 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.79e-04 | 41 | 58 | 3 | PS50014 | |
| Domain | BROMO | 2.99e-04 | 42 | 58 | 3 | SM00297 | |
| Domain | Bromodomain | 2.99e-04 | 42 | 58 | 3 | IPR001487 | |
| Domain | - | 2.99e-04 | 42 | 58 | 3 | 1.20.920.10 | |
| Domain | NPIP | 8.42e-04 | 14 | 58 | 2 | IPR009443 | |
| Domain | UDENN | 1.11e-03 | 16 | 58 | 2 | PS50946 | |
| Domain | DDENN | 1.11e-03 | 16 | 58 | 2 | PS50947 | |
| Domain | DENN | 1.11e-03 | 16 | 58 | 2 | SM00799 | |
| Domain | dDENN | 1.11e-03 | 16 | 58 | 2 | SM00801 | |
| Domain | DENN | 1.11e-03 | 16 | 58 | 2 | PF02141 | |
| Domain | dDENN_dom | 1.11e-03 | 16 | 58 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.11e-03 | 16 | 58 | 2 | IPR005113 | |
| Domain | dDENN | 1.11e-03 | 16 | 58 | 2 | PF03455 | |
| Domain | DENN | 1.11e-03 | 16 | 58 | 2 | PS50211 | |
| Domain | DENN_dom | 1.11e-03 | 16 | 58 | 2 | IPR001194 | |
| Domain | Bromodomain_CS | 2.94e-03 | 26 | 58 | 2 | IPR018359 | |
| Domain | SET | 8.99e-03 | 46 | 58 | 2 | SM00317 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.50e-05 | 26 | 38 | 3 | MM14793 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.93e-04 | 42 | 38 | 3 | M27272 | |
| Pubmed | BCL9L NCOA6 KMT2D RBM12 CHERP RBM33 BRD4 YLPM1 SSBP2 RERE BCL9 CASZ1 PHF21A | 2.34e-15 | 268 | 64 | 13 | 33640491 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA6 KMT2D BCL11B SSBP2 RERE ZMIZ1 BCL9 PRDM16 PHF21A | 9.01e-10 | 351 | 64 | 10 | 38297188 |
| Pubmed | BCL9L NCOA6 HNF1A KMT2D RBM12 FAM120A RBM33 CNOT10 YLPM1 ETV5 SSBP2 RERE ZMIZ1 BCL9 PRDM16 PHF21A | 4.60e-09 | 1429 | 64 | 16 | 35140242 | |
| Pubmed | ATXN2L NCOA6 KMT2D RBM12 FAM120A RBM33 ZNF652 BRD4 ETV5 CSTF3 BCL9 PHF21A | 7.00e-07 | 1103 | 64 | 12 | 34189442 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.44e-06 | 774 | 64 | 10 | 15302935 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.94e-06 | 457 | 64 | 8 | 32344865 | |
| Pubmed | 2.13e-06 | 14 | 64 | 3 | 28174279 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.30e-06 | 220 | 64 | 6 | 35785414 | |
| Pubmed | Partial USH2A deletions contribute to Usher syndrome in Denmark. | 3.33e-06 | 2 | 64 | 2 | 25804404 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38811552 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 36211334 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15371335 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20682801 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 33767438 | ||
| Pubmed | 9.24e-06 | 152 | 64 | 5 | 38360978 | ||
| Pubmed | VGF BCL11B FAM120A FAM171A2 NUMBL RPTOR YLPM1 ZBTB22 RIMS1 BCL9 | 9.89e-06 | 963 | 64 | 10 | 28671696 | |
| Pubmed | Discovery of a hidden transient state in all bromodomain families. | 9.99e-06 | 3 | 64 | 2 | 33468647 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 34545187 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33649334 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20637214 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIVEP3 FAM120A NUMBL RPTOR SBF2 CSTF3 PARD3B RIMS1 RERE ZMIZ1 CASZ1 BRWD3 | 1.51e-05 | 1489 | 64 | 12 | 28611215 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.56e-05 | 289 | 64 | 6 | 23752268 | |
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 2.00e-05 | 4 | 64 | 2 | 18463160 | |
| Pubmed | Inducing mutations in the mouse genome with the chemical mutagen ethylnitrosourea. | 2.00e-05 | 4 | 64 | 2 | 16972005 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 19699733 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.09e-05 | 180 | 64 | 5 | 35198878 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.21e-05 | 1105 | 64 | 10 | 35748872 | |
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 3.32e-05 | 5 | 64 | 2 | 24360964 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 3.32e-05 | 5 | 64 | 2 | 32808927 | |
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 3.32e-05 | 5 | 64 | 2 | 30760710 | |
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 3.32e-05 | 5 | 64 | 2 | 16301216 | |
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 17052462 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 19328798 | ||
| Pubmed | BCL11B FAM120A DROSHA RPTOR BRD4 RERE PRDM16 PHIP BRWD3 PHF21A | 3.49e-05 | 1116 | 64 | 10 | 31753913 | |
| Pubmed | 3.73e-05 | 35 | 64 | 3 | 33864728 | ||
| Pubmed | 4.64e-05 | 709 | 64 | 8 | 22988430 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 17113272 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 21399610 | ||
| Pubmed | Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. | 4.98e-05 | 6 | 64 | 2 | 30760720 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 15574752 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 4.98e-05 | 6 | 64 | 2 | 25184676 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 8896557 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 4.98e-05 | 6 | 64 | 2 | 17021013 | |
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 30366904 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 20058854 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 20473688 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 9502196 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 19556342 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.26e-05 | 398 | 64 | 6 | 35016035 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 9.27e-05 | 8 | 64 | 2 | 19683999 | |
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 17178841 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 18484607 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 16545802 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 9.27e-05 | 8 | 64 | 2 | 28296634 | |
| Pubmed | 9.39e-05 | 399 | 64 | 6 | 35987950 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 9.95e-05 | 130 | 64 | 4 | 35545047 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.14e-04 | 807 | 64 | 8 | 22681889 | |
| Pubmed | 1.15e-04 | 808 | 64 | 8 | 20412781 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 35296311 | ||
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 1.19e-04 | 9 | 64 | 2 | 23144817 | |
| Pubmed | Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis. | 1.19e-04 | 9 | 64 | 2 | 19251658 | |
| Pubmed | 1.21e-04 | 418 | 64 | 6 | 34709266 | ||
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | 1.23e-04 | 419 | 64 | 6 | 33001583 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.31e-04 | 265 | 64 | 5 | 19240061 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 1.49e-04 | 10 | 64 | 2 | 24618850 | |
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 24239741 | ||
| Pubmed | Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. | 1.49e-04 | 10 | 64 | 2 | 20721975 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.57e-04 | 1082 | 64 | 9 | 38697112 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.78e-04 | 861 | 64 | 8 | 36931259 | |
| Pubmed | Oxidative stress regulates progenitor behavior and cortical neurogenesis. | 1.81e-04 | 11 | 64 | 2 | 32041791 | |
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 2.17e-04 | 12 | 64 | 2 | 27824329 | |
| Pubmed | Common variants at five new loci associated with early-onset inflammatory bowel disease. | 2.17e-04 | 12 | 64 | 2 | 19915574 | |
| Pubmed | 2.17e-04 | 12 | 64 | 2 | 35132438 | ||
| Pubmed | Interplay of BAF and MLL4 promotes cell type-specific enhancer activation. | 2.17e-04 | 12 | 64 | 2 | 33712604 | |
| Pubmed | Thalamocortical axons regulate neurogenesis and laminar fates in the early sensory cortex. | 2.17e-04 | 12 | 64 | 2 | 35613048 | |
| Pubmed | 2.25e-04 | 469 | 64 | 6 | 27634302 | ||
| Pubmed | 2.39e-04 | 65 | 64 | 3 | 22496869 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 2.57e-04 | 13 | 64 | 2 | 17761849 | |
| Pubmed | 2.57e-04 | 13 | 64 | 2 | 18077585 | ||
| Pubmed | Excess NF-κB induces ectopic odontogenesis in embryonic incisor epithelium. | 2.57e-04 | 13 | 64 | 2 | 25376721 | |
| Pubmed | 2.57e-04 | 13 | 64 | 2 | 35289744 | ||
| Pubmed | 2.94e-04 | 493 | 64 | 6 | 15368895 | ||
| Pubmed | 2.99e-04 | 14 | 64 | 2 | 12482968 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.07e-04 | 934 | 64 | 8 | 33916271 | |
| Pubmed | The zinc finger/RING domain protein Unkempt regulates cognitive flexibility. | 3.45e-04 | 15 | 64 | 2 | 34381067 | |
| Pubmed | 3.45e-04 | 15 | 64 | 2 | 17925232 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.54e-04 | 954 | 64 | 8 | 36373674 | |
| Pubmed | 3.65e-04 | 75 | 64 | 3 | 20571754 | ||
| Pubmed | BCL9L GORASP2 NUMBL RBM33 DROSHA CNOT10 ZNF652 CSTF3 CASZ1 MFF | 3.85e-04 | 1497 | 64 | 10 | 31527615 | |
| Pubmed | 3.93e-04 | 733 | 64 | 7 | 34672954 | ||
| Pubmed | 3.93e-04 | 16 | 64 | 2 | 24368734 | ||
| Pubmed | Genome-wide meta-analysis identifies new susceptibility loci for migraine. | 4.10e-04 | 78 | 64 | 3 | 23793025 | |
| Pubmed | 4.45e-04 | 17 | 64 | 2 | 26180087 | ||
| Pubmed | 4.92e-04 | 83 | 64 | 3 | 28794006 | ||
| Pubmed | Fine mapping of a QTL region with large effects on growth and fatness on mouse chromosome 2. | 5.00e-04 | 18 | 64 | 2 | 15769905 | |
| Pubmed | Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape? | 5.00e-04 | 18 | 64 | 2 | 26921296 | |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 5.00e-04 | 18 | 64 | 2 | 17500065 | |
| Pubmed | 5.00e-04 | 18 | 64 | 2 | 17589506 | ||
| Pubmed | 5.20e-04 | 549 | 64 | 6 | 38280479 | ||
| Pubmed | 5.59e-04 | 19 | 64 | 2 | 22629441 | ||
| Interaction | EGR2 interactions | 1.88e-09 | 171 | 60 | 9 | int:EGR2 | |
| Interaction | AR interactions | BCL9L NCOA6 KMT2D RBM12 CHERP RBM33 BRD4 YLPM1 MED12L ETV5 CSTF3 SSBP2 RERE ZMIZ1 BCL9 CASZ1 PHF21A | 2.67e-09 | 992 | 60 | 17 | int:AR |
| Interaction | SP7 interactions | 2.71e-07 | 304 | 60 | 9 | int:SP7 | |
| Interaction | H3C14 interactions | 3.98e-07 | 156 | 60 | 7 | int:H3C14 | |
| Interaction | SMG7 interactions | 4.06e-07 | 319 | 60 | 9 | int:SMG7 | |
| Interaction | TLE3 interactions | 1.59e-06 | 376 | 60 | 9 | int:TLE3 | |
| Interaction | PHIP interactions | 1.91e-06 | 197 | 60 | 7 | int:PHIP | |
| Interaction | NUP35 interactions | 4.24e-06 | 424 | 60 | 9 | int:NUP35 | |
| Interaction | SOX7 interactions | 4.52e-06 | 82 | 60 | 5 | int:SOX7 | |
| Interaction | GSC interactions | 6.05e-06 | 87 | 60 | 5 | int:GSC | |
| Interaction | KDM6A interactions | 8.60e-06 | 162 | 60 | 6 | int:KDM6A | |
| Interaction | ALG13 interactions | 1.72e-05 | 183 | 60 | 6 | int:ALG13 | |
| Interaction | TBR1 interactions | 2.17e-05 | 113 | 60 | 5 | int:TBR1 | |
| Interaction | KMT2B interactions | 4.25e-05 | 130 | 60 | 5 | int:KMT2B | |
| Interaction | CEBPA interactions | ATXN2L NCOA6 HNF1A KMT2D RBM12 FAM120A RBM33 ZNF652 BRD4 ETV5 CSTF3 BCL9 PHF21A | 6.07e-05 | 1245 | 60 | 13 | int:CEBPA |
| Interaction | PYGO1 interactions | 7.79e-05 | 28 | 60 | 3 | int:PYGO1 | |
| Interaction | TOP3B interactions | HIVEP3 NCOA6 GORASP2 KMT2D FAM120A RBM33 CNOT10 RPTOR BRD4 SBF2 BCL9 DYSF PRDM16 CASZ1 | 8.14e-05 | 1470 | 60 | 14 | int:TOP3B |
| Interaction | CRX interactions | 1.07e-04 | 254 | 60 | 6 | int:CRX | |
| Interaction | TAF1 interactions | 1.22e-04 | 260 | 60 | 6 | int:TAF1 | |
| Interaction | ETV5 interactions | 1.28e-04 | 33 | 60 | 3 | int:ETV5 | |
| Interaction | LHX4 interactions | 1.35e-04 | 166 | 60 | 5 | int:LHX4 | |
| Interaction | KMT2D interactions | 1.47e-04 | 169 | 60 | 5 | int:KMT2D | |
| Interaction | GATA1 interactions | 1.55e-04 | 171 | 60 | 5 | int:GATA1 | |
| Interaction | PRMT2 interactions | 1.56e-04 | 91 | 60 | 4 | int:PRMT2 | |
| Interaction | SOX9 interactions | 2.00e-04 | 97 | 60 | 4 | int:SOX9 | |
| Interaction | CELF1 interactions | 2.12e-04 | 288 | 60 | 6 | int:CELF1 | |
| Interaction | ISL1 interactions | 2.47e-04 | 41 | 60 | 3 | int:ISL1 | |
| Interaction | ISL2 interactions | 2.47e-04 | 41 | 60 | 3 | int:ISL2 | |
| Interaction | FUBP3 interactions | 2.50e-04 | 297 | 60 | 6 | int:FUBP3 | |
| Interaction | ZMYND8 interactions | 2.60e-04 | 191 | 60 | 5 | int:ZMYND8 | |
| Cytoband | 20q11.21 | 1.99e-03 | 47 | 64 | 2 | 20q11.21 | |
| Cytoband | 19p13.1 | 2.07e-03 | 48 | 64 | 2 | 19p13.1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.32e-03 | 25 | 39 | 2 | 775 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.32e-03 | 25 | 39 | 2 | 504 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.44e-03 | 34 | 39 | 2 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.09e-03 | 718 | 39 | 6 | 28 | |
| GeneFamily | PDZ domain containing | 4.27e-03 | 152 | 39 | 3 | 1220 | |
| GeneFamily | RNA binding motif containing | 1.08e-02 | 213 | 39 | 3 | 725 | |
| GeneFamily | PHD finger proteins | 1.61e-02 | 90 | 39 | 2 | 88 | |
| GeneFamily | WD repeat domain containing | 1.87e-02 | 262 | 39 | 3 | 362 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 1.19e-05 | 465 | 61 | 8 | M39066 | |
| Disease | Intellectual Disability | 2.89e-07 | 447 | 60 | 9 | C3714756 | |
| Disease | forced expiratory volume | TBXAS1 ATXN2L NCOA6 DROSHA PCDH15 PARD3B BCL9 MN1 PHIP CASZ1 | 3.98e-06 | 789 | 60 | 10 | EFO_0004314 |
| Disease | irritable bowel syndrome | 7.17e-06 | 131 | 60 | 5 | EFO_0000555 | |
| Disease | frontotemporal dementia and/or amyotrophic lateral sclerosis-2 (implicated_via_orthology) | 1.22e-05 | 3 | 60 | 2 | DOID:0060214 (implicated_via_orthology) | |
| Disease | Parkinson's disease 22 (implicated_via_orthology) | 1.22e-05 | 3 | 60 | 2 | DOID:0080504 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy, Jokela type (implicated_via_orthology) | 1.22e-05 | 3 | 60 | 2 | DOID:0081356 (implicated_via_orthology) | |
| Disease | Antihypertensive use measurement | 1.65e-05 | 265 | 60 | 6 | EFO_0009927 | |
| Disease | cognitive function measurement | ATXN2L CELF4 KMT2D BCL11B FAM120A CNOT10 BARHL2 MED12L PARD3B SSBP2 USH2A CHCHD2P9 | 2.65e-05 | 1434 | 60 | 12 | EFO_0008354 |
| Disease | Chromosome 1p36 Deletion Syndrome | 4.05e-05 | 5 | 60 | 2 | C1842870 | |
| Disease | Usher Syndrome, Type II | 4.05e-05 | 5 | 60 | 2 | C1568249 | |
| Disease | reaction time measurement | 5.40e-05 | 658 | 60 | 8 | EFO_0008393 | |
| Disease | neurotic disorder | 5.44e-05 | 101 | 60 | 4 | EFO_0004257 | |
| Disease | Abnormal corpus callosum morphology | 6.07e-05 | 6 | 60 | 2 | C1842581 | |
| Disease | mean arterial pressure | 6.75e-05 | 499 | 60 | 7 | EFO_0006340 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 9.66e-05 | 364 | 60 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | isovalerate measurement | 1.45e-04 | 9 | 60 | 2 | EFO_0021051 | |
| Disease | Abnormality of the face | 1.45e-04 | 9 | 60 | 2 | C4025871 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.48e-04 | 566 | 60 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | alcohol consumption measurement | ATXN2L HNF1A BCL11B NPIPB9 RPTOR CSTF3 RERE SEZ6L2 CHCHD2P9 PRDM16 | 1.86e-04 | 1242 | 60 | 10 | EFO_0007878 |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 3.13e-04 | 13 | 60 | 2 | EFO_0020131 | |
| Disease | sexual dimorphism measurement | 3.74e-04 | 1106 | 60 | 9 | EFO_0021796 | |
| Disease | pulse pressure measurement | TBXAS1 HIVEP3 FAM171A2 RBM33 RPTOR SBF2 DYSF PRDM16 CASZ1 DENND4C | 4.62e-04 | 1392 | 60 | 10 | EFO_0005763 |
| Disease | body fat percentage | 4.67e-04 | 488 | 60 | 6 | EFO_0007800 | |
| Disease | nervousness | 4.79e-04 | 16 | 60 | 2 | NCIT_C74532 | |
| Disease | smoking status measurement | 5.29e-04 | 1160 | 60 | 9 | EFO_0006527 | |
| Disease | myeloid white cell count | 5.95e-04 | 937 | 60 | 8 | EFO_0007988 | |
| Disease | Feeding difficulties | 6.09e-04 | 18 | 60 | 2 | C0232466 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 7.42e-04 | 200 | 60 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | risk-taking behaviour | 8.90e-04 | 764 | 60 | 7 | EFO_0008579 | |
| Disease | Neurodevelopmental Disorders | 9.11e-04 | 93 | 60 | 3 | C1535926 | |
| Disease | S-6-hydroxywarfarin measurement | 9.14e-04 | 368 | 60 | 5 | EFO_0803326 | |
| Disease | executive function measurement | 1.01e-03 | 376 | 60 | 5 | EFO_0009332 | |
| Disease | testosterone measurement | 1.04e-03 | 1275 | 60 | 9 | EFO_0004908 | |
| Disease | hearing impairment | 1.06e-03 | 98 | 60 | 3 | C1384666 | |
| Disease | airway responsiveness measurement | 1.09e-03 | 24 | 60 | 2 | EFO_0006897 | |
| Disease | bipolar disorder | 1.11e-03 | 577 | 60 | 6 | MONDO_0004985 | |
| Disease | anterior thigh muscle fat infiltration measurement | 1.49e-03 | 28 | 60 | 2 | EFO_0020936 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 1.49e-03 | 28 | 60 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.52e-03 | 111 | 60 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | Prostatic Neoplasms | 1.56e-03 | 616 | 60 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.56e-03 | 616 | 60 | 6 | C0376358 | |
| Disease | cerebral infarction (is_implicated_in) | 1.59e-03 | 29 | 60 | 2 | DOID:3526 (is_implicated_in) | |
| Disease | caudate nucleus volume | 1.71e-03 | 30 | 60 | 2 | EFO_0004830 | |
| Disease | granulocyte count | 1.79e-03 | 254 | 60 | 4 | EFO_0007987 | |
| Disease | waist circumference | 1.80e-03 | 429 | 60 | 5 | EFO_0004342 | |
| Disease | neutrophil count | 1.81e-03 | 1382 | 60 | 9 | EFO_0004833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHQPMQPQPPVHPMQ | 136 | Q99217 | |
| PPHVPPQMLNIPQTS | 6 | Q5T035 | |
| QPPPRPVHLQPMQFS | 991 | O60885 | |
| PMQFSTHIQQPPPPQ | 1001 | O60885 | |
| IPQMPQIPASVPHLP | 1126 | Q86V15 | |
| PIPHIDPSRPMTPQQ | 1001 | Q8IUX7 | |
| QTQQAPHLMPPPFLV | 576 | Q6RI45 | |
| QMRAAPRPAPVAQPP | 21 | Q9Y6H1 | |
| GAPHPPQVMLLHPPQ | 981 | Q8WWM7 | |
| QVAVFLPPPHMQPPF | 476 | Q9Y6R0 | |
| NLNPMFLGPLNPVNP | 271 | Q9NTZ6 | |
| PPPLMPMSQPQFRPH | 646 | Q96EV2 | |
| QLIQPRAPGPHAMPV | 801 | Q9H3S7 | |
| RQDVPPSPPQHQRMP | 1156 | Q8TEW8 | |
| HPNLPSVPLPQDPMR | 2036 | Q86YW9 | |
| PNLNLNLPAPHIMPG | 316 | Q9H8Y8 | |
| PSPQQARVCPPHMLP | 201 | Q9GZY8 | |
| ENPNPHMAFQKVPRP | 466 | Q86WG5 | |
| LPQPPNMLDHRQWPP | 16 | Q8NBC4 | |
| PPVPLQGPHARYNMN | 346 | O75564 | |
| LSPQPPPPILHHQGM | 316 | Q96HM7 | |
| PPPILHHQGMPRFPQ | 321 | Q96HM7 | |
| TQQMIPFQPRHLAPP | 586 | Q12996 | |
| QNNIPIAPAPPPMLA | 241 | Q96BD5 | |
| QPLHPSYQQPLMPPV | 466 | P20823 | |
| FAVPRPPHQPLQMPK | 191 | P41161 | |
| VPPHVPPQMLNIPQT | 356 | Q9NZB2 | |
| NRMGRQPPPPTQQHS | 241 | O75200 | |
| NRMGRQPPPPTQQHS | 241 | A6NHN6 | |
| PLPQPSPFMPRRHIH | 876 | Q86UR5 | |
| FPQPDPQRPQMPGHS | 576 | A8MVW0 | |
| QVLRPPGPSPHMAQQ | 786 | Q14686 | |
| PPQHLSPPQPGRVRM | 171 | I0J062 | |
| LPPNNQSPPRFPQLM | 606 | Q96QU1 | |
| QMRAAPRPAPVAQPP | 21 | Q5T1J5 | |
| NPMHRLLNPFQPSPK | 386 | Q9C0K0 | |
| MQRPPHFRGPFPPHQ | 516 | Q8IWX8 | |
| QMPSPNAVGPNIPPH | 1091 | O00512 | |
| PGQQPLSHEPPPAML | 1161 | Q86UU0 | |
| GPPPQQNLMVSHPLR | 1461 | Q86UU0 | |
| HFMQNIPFPSPQRPR | 351 | Q5VZ89 | |
| MYRTPPAPHPQLQRP | 341 | Q9NY43 | |
| PMPPRQFHQLAAQGP | 1561 | O75923 | |
| NRMGRQPPPPTQQHS | 256 | F8W1W9 | |
| VGSRHPLMQPPQQAP | 331 | Q10571 | |
| PVSPRLHVPLMPAQP | 306 | P00748 | |
| QTPEIAPLMQPPPHL | 4626 | O75445 | |
| CPIRPPFPNHQMRHP | 96 | Q9NRR4 | |
| PFPNHQMRHPFPVPP | 101 | Q9NRR4 | |
| LMNAVPPGPNRPNFP | 271 | P81877 | |
| APLPPPAPSQFQARM | 221 | O15240 | |
| QVCPARMPQQPPLHY | 841 | Q9HAZ2 | |
| RMPQQPPLHYAKPSP | 846 | Q9HAZ2 | |
| FVPPMPLPRQNHEPV | 211 | Q96D42 | |
| QGHLLPPCLLPPPQM | 46 | Q2M3A8 | |
| PSAHPPPLQLMPQSQ | 981 | Q9P2R6 | |
| MGTPRAQHPPPPQLL | 1 | Q6UXD5 | |
| AINPNHPLAQMPLPP | 221 | Q8N122 | |
| QAFPQPPPMIPQQQR | 401 | Q9BZC1 | |
| KPVFQPVHPIQPIQM | 721 | Q9H9A5 | |
| PNPSRQHQPSPMARP | 311 | P24557 | |
| EQTQQAPHLMPPPFL | 576 | Q8WWQ0 | |
| QSMPHRKPVPHPNPT | 1516 | Q6ZQQ2 | |
| PQLMPHPANIPFRQP | 1206 | Q5T1R4 | |
| QMQCVLQPHHLPPPP | 71 | P49750 | |
| NMNPVSTLPPRPIPH | 531 | Q9Y2D9 | |
| PQMPAQPALPQLPRR | 36 | A0A1B0GWB2 | |
| HPPRPLLPLDMQGNQ | 411 | O15209 | |
| PNMSALPPPPANHND | 546 | Q9ULJ6 | |
| PQPLMPTQPPAHALQ | 3326 | O14686 |